AimsDoxorubicin‐induced cardiotoxicity (DIC) is a significant cause of mortality in cancer care. This study was conducted to establish the frequency of DIC in Zimbabwean breast cancer patients on doxorubicin and to test the DIC predictive power of genetic biomarkers.MethodsA cohort of 50 Zimbabwean breast cancer patients treated with doxorubicin were followed up for 12 months with serial echocardiography and genotyped for UGTA1A6*4, SLC28A3 and RARG. Eleven per cent of the patients experienced DIC.ResultsThe frequencies of SLC28A3 (rs7853758), UGT1A6*4 (rs17863783) and RARG (rs2229774) were 60.7%, 17.9% and 14.3%, respectively. No association between DIC and the three variants was observed.ConclusionsThis is the first study on the prevalence of DIC and associated genetic biomarker predictive evaluation in Zimbabwean breast cancer patients. The genetic frequencies observed in our study were different to those reported in other populations. A larger sample size with a longer follow‐up time will be necessary in future studies.
AIMS Doxorubicin-induced cardiotoxicity (DIC) is a significant cause of
mortality in cancer care. This study was conducted to establish the
frequency of DIC in Zimbabwean breast cancer patients on doxorubicin and
to test the DIC predictive power of genetic biomarkers. METHODS A cohort
of 50 Zimbabwean breast cancer patients treated with doxorubicin were
followed up for 12 months with serial echocardiography and genotyped for
UGTA1A6*4, SLC28A3 and RARG. 11% of the patients experienced DIC.
RESULTS The frequency of SLC28A3 (rs7853758), UGT1A6*4 (rs17863783) and
RARG (rs2229774) was 60.7%, 17.9% and 14.3% respectively. No
association between DIC and the three variants was observed. CONCLUSIONS
This is the first study on the prevalence of DIC and associated genetic
biomarker predictive evaluation in Zimbabwean breast cancer patients.
The genetic frequencies observed in our study was different to that
reported in other populations. A larger sample size with a longer follow
up time will be necessary in future studies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.